Rigel Pharmaceuticals, Inc. Stock Performance

Open $50.07	Prev. Close $48.63	Circuit Range N/A
Day Range $49.06 - $50.07	Year Range $25.07 - $52.05	Volume 9,102
Average Traded $49.47

Rigel Pharmaceuticals, Inc. Share Price Today

As of 10 October 2026, Rigel Pharmaceuticals, Inc.'s share price is $49.24. The stock opened at $50.07, compared to its previous close of $48.63. During today's trading session, Rigel Pharmaceuticals, Inc.'s share price traded between $49.06 and $50.07, with an average price of $49.56. Over the past 52 weeks, the stock has recorded a high of $52.05 and a low of $25.07. In terms of performance, Rigel Pharmaceuticals, Inc.'s share price has risen by 70.29% over the last six months and is up 55.92% on a year-on-year basis.

Rigel Pharmaceuticals, Inc. Share Price Chart

$49.06$50.07

Rigel Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap $885.68M	PE Ratio (TTM) 2.85	Dividend Yield 0.00%
EPS (TTM) $17.23	Revenue (TTM) $294.28B	Return On Equity (TTM) 75.67%
Profit Margin 124.72%	Debt to Equity 0.09	Quarterly Earnings Growth YoY -38.03%

Rigel Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$69.46	$69.80	$58.82	$78.70
Net Profit	$27.90	$268.07	$8.65	$17.29
Net Profit Margin	40.17%	384.05%	14.71%	21.97%
Income Change	N/A	860.82%	-96.77%	99.88%

Rigel Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars	2022	2023	2024	2025
Revenue	$120.24	$116.88	$179.28	$294.28
Net Profit	-$58.57	-$25.09	$17.49	$367.02
Net Profit Margin	-48.71%	-21.47%	9.76%	124.72%
Income Change	N/A	57.16%	169.71%	1998.46%

About Rigel Pharmaceuticals, Inc.

Rigel Pharmaceuticals Inc develops small-molecule drugs for autoimmune, cancer-related, and viral diseases. The firm's primary drug is an oral rheumatoid arthritis drug candidate that has been licensed to AstraZeneca. Astra has taken overall responsibility for developing and marketing the drug and will pay Rigel royalties and milestone payments. Its pipeline product includes TAVALISSE (fostamatinib disodium hexahydrate) tablets, REZLIDHIA (olutasidenib), GAVRETO (pralsetinib), R289, and Ocadusertib (Systemic) - Eli Lilly.

Rigel Pharmaceuticals, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$48.09	$49.15	+2.20%
Sep 2026	$46.81	$48.09	+2.64%
Aug 2026	$36.67	$46.85	+27.29%
Jul 2026	$38.97	$36.81	-5.90%
Jun 2026	$30.35	$39.12	+28.22%
May 2026	$29.44	$30.51	+5.52%
Apr 2026	$27.44	$28.91	+6.84%
Mar 2026	$33.88	$27.07	-21.85%
Feb 2026	$34.73	$34.63	-0.03%
Jan 2026	$42.67	$34.64	-19.06%
Dec 2025	$49.75	$42.80	-15.33%
Nov 2025	$31.30	$50.55	+60.05%

RIGL Share Price FAQs

What is Rigel Pharmaceuticals, Inc. share price today?

Rigel Pharmaceuticals, Inc. share price today is $49.24 as on October 10, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Rigel Pharmaceuticals, Inc. stock?

The 52 week high of Rigel Pharmaceuticals, Inc. stock is $52.05, while the 52 week low is $25.07 as of 10 Oct '26.

What is RIGL's market capitalisation today?

RIGL market capitalisation is $885.68M as of October 10, 2026, at 6:21 pm IST.

What is RIGL's net income for the last quarter?

RIGL's net income for the last quarter is 17.29B USD.

What is the 5 year returns of RIGL?

The 5 year returns of RIGL is 46.55% as on 10 Oct '26.

What is the high & low stock price of RIGL today?

RIGL stock price hit a high of $50.07 and low of $49.06 as of 10 Oct '26.

Can I buy RIGL shares in India?

Yes. You can buy RIGL in India by opening an international trading account.